Home / Research Articles Hub / Prevalence and Treatment of Diabetes in China, 201...
🧬 Medicine & Biology OpenAlex

Prevalence and Treatment of Diabetes in China, 2013-2018

📅 Published: December 28, 2021 👤 Limin Wang, Wen Peng, Zhenping Zhao et al. 📖 JAMA 📊 948 citations
AI-Generated Summary

Importance: Recent data on prevalence, awareness, treatment, and risk factors of diabetes in China is necessary for interventional efforts. Conclusions and Relevance: In this survey study, the estimated diabetes prevalence was high and increased from 2013 to 2018.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

Key Findings
  • 1 Objective: To estimate trends in prevalence, awareness, treatment, and risk factors of diabetes in China based on national data.
  • 2 Design, Setting, and Participants: Cross-sectional nationally representative survey data collected in adults aged 18 years or older in mainland China from 170 287 participants in the 2013-2014 years and 173 642 participants in the 2018-2019 years.
  • 3 Exposures: Fasting plasma glucose and hemoglobin A1c levels were measured for all participants.
Why It Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source:

Read Full Paper at OpenAlex
More Medicine & Biology Papers ← Back to Hub 📚 Learning Hub